Variant report

Variant	rs191705962
Chromosome Location	chr2:152616733-152616734
allele	A/C
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:152615094..152617806-chr2:152640783..152643681,2	K562	blood:
2	chr2:152567546..152569440-chr2:152615206..152617035,2	K562	blood:
3	chr2:152614524..152619932-chr2:152620577..152626819,11	K562	blood:
4	chr2:152616288..152619244-chr2:152629461..152632128,2	K562	blood:
5	chr2:152615094..152618024-chr2:152639649..152643681,5	K562	blood:
6	chr2:152610387..152612383-chr2:152614274..152616912,2	K562	blood:
7	chr2:152612871..152615021-chr2:152615228..152617086,7	K562	blood:
8	chr2:152610150..152612599-chr2:152612942..152616912,4	K562	blood:
9	chr2:152615779..152617906-chr2:152682702..152684733,2	K562	blood:

No data

Extended variants
information (count: 5 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv934136	chr2:152308156-152664443	Genic enhancers Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	6 gene(s)	inside rSNPs	diseases
2	nsv1005746	chr2:152361972-153059840	Strong transcription Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
3	nsv535984	chr2:152361972-153059840	Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
4	esv3414820	chr2:152616581-152618629	Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Strong transcription Genic enhancers	Chromatin interactive region	n/a	inside rSNPs	diseases
5	esv2592137	chr2:152616645-152618365	Enhancers Weak transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	n/a	inside rSNPs	diseases

No data

Chromatin state (count:33 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:152595800-152620200	Weak transcription	Primary B cells from cord blood	blood
2	chr2:152597200-152618400	Weak transcription	Aorta	Aorta
3	chr2:152598200-152618600	Weak transcription	Monocytes-CD14+_RO01746	blood
4	chr2:152609400-152617200	Enhancers	Skeletal Muscle Male	skeletal muscle
5	chr2:152611000-152632400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr2:152611200-152617800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
7	chr2:152611200-152620400	Weak transcription	Fetal Muscle Leg	muscle
8	chr2:152611600-152622600	Enhancers	K562	blood
9	chr2:152612000-152622200	Enhancers	Skeletal Muscle Female	skeletal muscle
10	chr2:152613200-152616800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr2:152614600-152622000	Weak transcription	Fetal Lung	lung
12	chr2:152614600-152622200	Weak transcription	Left Ventricle	heart
13	chr2:152614600-152638000	Weak transcription	Pancreas	Pancrea
14	chr2:152615000-152622400	Weak transcription	Adipose Nuclei	Adipose
15	chr2:152615400-152616800	Enhancers	Psoas Muscle	Psoas
16	chr2:152615400-152622400	Weak transcription	Lung	lung
17	chr2:152615600-152623000	Weak transcription	Primary monocytes fromperipheralblood	blood
18	chr2:152616200-152619200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr2:152616400-152617200	Flanking Active TSS	HepG2	liver
20	chr2:152616400-152617200	Enhancers	HSMMtube	muscle
21	chr2:152616600-152616800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
22	chr2:152616600-152616800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
23	chr2:152616600-152616800	Enhancers	Placenta	Placenta
24	chr2:152616600-152616800	Enhancers	Placenta Amnion	Placenta Amnion
25	chr2:152616600-152617000	Enhancers	ES-I3 Cell Line	embryonic stem cell
26	chr2:152616600-152617000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr2:152616600-152617000	Enhancers	HUES6 Cell Line	embryonic stem cell
28	chr2:152616600-152617000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr2:152616600-152617200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr2:152616600-152617200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr2:152616600-152617200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
32	chr2:152616600-152617200	Enhancers	Right Atrium	heart
33	chr2:152616600-152620200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links